NovaScan, a clinical-stage oncology company based in Chicago, has announced the appointment of luminaries in interventional pulmonology and gastroenterology to lead initiatives in lung and GI, respectively.
NovaScan’s lung Scientific Advisory Board will be led by D. Kyle Hogarth, MD FCCP. A world-renowned authority in the diagnosis, management, and treatment of lung cancer through bronchoscopy, Dr Hogarth is a Professor of Medicine at the University of Chicago and is the Director of Bronchoscopy. He’s also the founder of the Society for Advanced Bronchoscopy, and an accomplished researcher in the minimally invasive diagnosis and treatment of lung cancer.